Events

Gain in-depth industry knowledge about the interaction between health insurance companies, service providers, doctors, patients and the pharmaceutical and medical technology industry. You will get an overview of the stakeholders and their interests and learn to analyse our healthcare system "layer by layer". Our experienced expert takes up current topics in the appropriate context and conveys them in a practical way.

This one-day programme empowers Commercial and Medical Affairs managers to become highly effective contributors to the cross-functional process required for a successful omnichannel pharma brand launch.

Execute a Comprehensive Market Strategy Across the Development Continuum, Demonstrate Value to Payers & Ensure Pre-Launch Readiness to Unlock Access to More Transformative CNS Treatments.

In the high-stakes world of biotechnology and pharmaceuticals, traditional valuation methods fall short. The industry presents unique challenges that require specialised expertise: High R&D Attrition Rates, Extended Investment Cycles and Complex IP Landscapes. This hands-on introductory course equips you with practical valuation tools essential for Financing rounds and investment decisions, Mergers & Acquisitions (M&A), Licensing deals and partnerships, Strategic development planning, Portfolio optimisation.

This course offers a unique opportunity to speed up your learning curve by giving you a comprehensive overview of the licensing process in the context of business development in the pharma-biotech world.

The Symposium is open to anyone working in or interested in regulatory affairs, and gathers delegates, speakers and exhibitors from across industry, regulatory bodies, academia and related sectors. In addition to hearing the latest insights and developments, it is also provides valuable opportunities to network and make new contacts.

Understanding value pricing in pharma’s multi-stakeholder and international environment is critical for pricing executives, and for all functions interacting with key stakeholders in the market access process. This course will teach you the techniques and approaches that have been proven to work best for value pricing in pharma.

Network with more than 550 policymakers, public-health experts, clinicians, patient groups, scientists, pharmaceutical executives, technology developers and investors and hear from your peers through a series of panel debates and practical sessions on how to build resilient, future-proofed health systems.

The Festival of Biologics brings together pharma and biotech, academics, research institutes, regulators, patients groups and payers together with their partners across the value chain to bring you from discovery to market.

This two-day programme equips you with important concepts, tools, and techniques that increase the impact of the Medical Affairs role, be it as a manager of teams or as a key contributor in cross-functional teams.

This conference will bring together stakeholders and policymakers to discuss the way forward following the UK’s Modern Industrial Strategy and what will be needed if its aims are to be achieved to reduce regulatory burdens and speed up innovation. Delegates will also examine the forthcoming Life Sciences Sector Plan, and plans for a streamlined and flexible regulatory framework with accelerated medicine approval processes, support for innovative therapies and increased alignment with international standards.

With 36 Sponsors and Exhibitors taking part in 2024 and over 230 pre-registered delegates from across the MedTech, Life Sciences and NHS sector, the Expo also incorporated a conference stream over the day with a mix of topics suited for the audience.